Bromocriptine and psychosis: a literature review.
Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactinomas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.
Boyd
A
A
Tulane Medical Center, Department of Psychiatry and Neurology, Tulane University, New Orleans, Louisiana.
D000568:Amenorrhea / Q000188:drug therapy; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy; D011618:Psychotic Disorders / Q000209:etiology*; D011644:Puerperal Disorders / Q000188:drug therapy
D001971:Bromocriptine